These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31847854)

  • 41. Institutional Conflicts of Interest in Academic Research.
    Resnik DB
    Sci Eng Ethics; 2019 Dec; 25(6):1661-1669. PubMed ID: 26446768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Financial conflicts of interest of OncoAlert: An informal oncology professional network.
    Powell K; Kakkilaya A; Haslam A; Prasad V
    J Cancer Policy; 2022 Dec; 34():100369. PubMed ID: 36396090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.
    Neuman J; Korenstein D; Ross JS; Keyhani S
    BMJ; 2011 Oct; 343():d5621. PubMed ID: 21990257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Financial Conflicts of Interest, Disclosure, and Academic Discipline.
    Bruton SV; Sacco DF; Didlake R
    J Empir Res Hum Res Ethics; 2016 Apr; 11(2):165-9. PubMed ID: 27009304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Responses of medical schools to institutional conflicts of interest.
    Ehringhaus SH; Weissman JS; Sears JL; Goold SD; Feibelmann S; Campbell EG
    JAMA; 2008 Feb; 299(6):665-71. PubMed ID: 18270355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethical management of conflict of interest: proposed standards for academic surgical societies.
    Minter RM; Angelos P; Coimbra R; Dale P; de Vera ME; Hardacre J; Hawkins W; Kirkwood K; Matthews JB; McLoughlin J; Peralta E; Schmidt M; Zhou W; Schwarze ML
    J Am Coll Surg; 2011 Nov; 213(5):677-82. PubMed ID: 21880513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials.
    Aneja A; Esquitin R; Shah K; Iyengar R; Nisenbaum R; Melo M; Matthewkutty S; Sethi SS; Mamdani M; Farkouh ME
    J Am Coll Cardiol; 2013 Mar; 61(11):1137-43. PubMed ID: 23395075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extent and impact of industry sponsorship conflicts of interest in dermatology research.
    Perlis CS; Harwood M; Perlis RH
    J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Influence of Disclosure and Ethics Education on Perceptions of Financial Conflicts of Interest.
    Sacco DF; Bruton SV; Hajnal A; Lustgraaf CJ
    Sci Eng Ethics; 2015 Aug; 21(4):875-94. PubMed ID: 25008103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.
    Yim R
    Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical trials. Proposed rules aim to curb financial conflicts of interest.
    Kaiser J
    Science; 2002 Jan; 295(5553):246-7. PubMed ID: 11786611
    [No Abstract]   [Full Text] [Related]  

  • 53. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
    Choudhry NK; Stelfox HT; Detsky AS
    JAMA; 2002 Feb; 287(5):612-7. PubMed ID: 11829700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Institutional review boards (IRBs) and conflict of interest.
    Shamoo AE
    Account Res; 1999; 7(2-4):201-12. PubMed ID: 11658176
    [No Abstract]   [Full Text] [Related]  

  • 55. Commentary: Disclosure's failings: what is the alternative?
    Kassirer JP
    Acad Med; 2009 Sep; 84(9):1180-1. PubMed ID: 19707054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coalition Priorité Cancer and the pharmaceutical industry in Quebec: conflicts of interest in the reimbursement of expensive cancer drugs?
    Hughes D; Williams-Jones B
    Healthc Policy; 2013 Aug; 9(1):52-64. PubMed ID: 23968674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IRBs and financial conflicts of interest.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):5. PubMed ID: 12374180
    [No Abstract]   [Full Text] [Related]  

  • 58. Institutional review boards and financial conflicts of interest.
    Maloney DM
    Hum Res Rep; 2002 Feb; 17(2):1-2. PubMed ID: 12374174
    [No Abstract]   [Full Text] [Related]  

  • 59. Disclosing conflicts of interest to research subjects: an ethical and legal analysis.
    Resnik DB
    Account Res; 2004; 11(2):141-59. PubMed ID: 15675055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Financial relationships between institutional review board members and industry.
    Campbell EG; Weissman JS; Vogeli C; Clarridge BR; Abraham M; Marder JE; Koski G
    N Engl J Med; 2006 Nov; 355(22):2321-9. PubMed ID: 17135585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.